Acta Scientific Pharmaceutical Sciences (ISSN: 2581-883X)

Opinion Volume 4 Issue 6

An Overview on Novel Coronavirus (COVID-19)

Suresh Ghotekar1*, Shreyas Pansambal2 and Rajeshwari Oza2

1Department of Chemistry, Sanjivani Arts, Commerce and Science College, Savitribai Phule Pune University, Maharashtra, India
2Department of Chemistry, S.N. Arts, D.J.M. Commerce and B.N.S. Science College, Savitribai Phule Pune University, Maharashtra, India

*Corresponding Author: Suresh Ghotekar, Department of Chemistry, Sanjivani Arts, Commerce and Science College, Savitribai Phule Pune University, Maharashtra, India.

Received: March 24, 2020; Published: May 20, 2020

×

In December 2019, a novel coronavirus (COVID-19) was reported in Wuhan, a city of 11 million people in central China. The initial cases were connected to exposures in a seafood market in Wuhan [1]. As of March 23 (11.00 AM), 2020, the WHO reported 294110 confirmed cases and 12944 confirmed deaths in 187 countries of the whole world. The infected people were experienced respiratory illness and coughs. Therefore, pathogen was soon identified as a COVID-19 which is closely related to sever acute respiratory syndrome CoV (SARS-CoV).

×

Citation

Citation: Suresh Ghotekar., et al. “An Overview on Novel Coronavirus (COVID-19)". Acta Scientific Pharmaceutical Sciences 4.6 (2020): 03-05.




Metrics

Acceptance rate33%
Acceptance to publication20-30 days
Impact Factor1.197

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is December 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"

Contact US